The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...

People with acid reflux often rely on acid-reducing medications to ease symptoms. Depending on the severity of your symptoms, over-the-counter (OTC) and prescription options are available.

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

If you’re looking for the best tablets under Rs. 10,000 in India, here’s a list for you. The tablets you see on this page are sorted by recency of launch, and are all currently available to buy in ...